Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 12:20 save search
Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC
Published: 2023-11-04 (Crawled : 12:20) - globenewswire.com
CADL | $6.04 3.78% 780K
|
| Email alert
Add to watchlist
preclinical therapeutics platform
Form 425 Twin Ridge Capital Acqui Filed by: Carbon Revolution … – StreetInsider.com
Published: 2023-10-06 (Crawled : 12:20) - spacfeed.com
ZVRA | $4.87 1.78% 91K
|
n/a
| Email alert
Add to watchlist
TAC | $6.1 430K
|
Utilities
| Email alert
Add to watchlist
Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results in Late-Breaking Science Session at 2023 AHA Hypertension Scientific Sessions
Published: 2023-09-10 (Crawled : 12:20) - globenewswire.com
MLYS | $12.425 0.69% 27K
|
| Email alert
Add to watchlist
sessions hypertension trial therapeutics results phase 2
Mineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension
Published: 2023-09-10 (Crawled : 12:20) - globenewswire.com
MLYS | $12.425 0.69% 27K
|
| Email alert
Add to watchlist
publication hypertension trial therapeutics results
BIOXCEL DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options
Published: 2023-09-02 (Crawled : 12:20) - prnewswire.com
BTAI 4 | $2.66 -3.27% 130K
|
Health Technology
| Email alert
Add to watchlist
deadline
BIOXCEL INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options
Published: 2023-08-26 (Crawled : 12:20) - prnewswire.com
BTAI 4 | $2.66 -3.27% 130K
|
Health Technology
| Email alert
Add to watchlist
BIOXCEL SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options
Published: 2023-08-19 (Crawled : 12:20) - prnewswire.com
BTAI 4 | $2.66 -3.27% 130K
|
Health Technology
| Email alert
Add to watchlist
BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS™ Immunotherapy for Cancer
Published: 2023-08-16 (Crawled : 12:20) - globenewswire.com
BCTX | $2.06 -11.21% 87K
|
Professional, Scientific, and T...
|
| O: 0.43%
H: 0.86%
C: 0.86%
institute cancer immunotherapy grant
Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
QLGN | $0.3054 -4.53% 130K
|
Health Technology
|
| O: -1.9%
H: 6.8%
C: 6.14%
update financial results
Allogene Therapeutics Appoints Earl Douglas as General Counsel
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ALLO | $3.5 -1.41% 450K
|
Health Technology
|
| O: -2.01%
H: 0.36%
C: -0.24%
therapeutics
Lilly Completes Acquisition of Sigilon Therapeutics
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: 0.0%
acquisition therapeutics
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
PBLA | $0.54 79K
|
Professional, Scientific, and T...
|
| O: 6.79%
H: 4.05%
C: -5.2%
sbp-101 europe patent
BIOXCEL DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options
Published: 2023-08-12 (Crawled : 12:20) - prnewswire.com
BTAI 4 | $2.66 -3.27% 130K
|
Health Technology
| Email alert
Add to watchlist
deadline
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
Published: 2023-08-11 (Crawled : 12:20) - globenewswire.com
ELTX | $9.33 1.08% 21K
|
|
| O: -2.2%
H: 2.25%
C: 2.25%
therapeutics financial results
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
Published: 2023-08-10 (Crawled : 12:20) - biospace.com/
APVO 3 d | $0.7694 -1.74% 450K
|
Health Technology
|
| O: -3.0%
H: 7.44%
C: -6.89%
business update therapeutics financial results
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
VERA | $46.27 -3.54% 250K
|
Professional, Scientific, and T...
|
| O: 1.14%
H: 7.49%
C: 5.03%
business update therapeutics financial results
Protagonist Receives $34 Million from Warrant Exercises
Published: 2023-08-09 (Crawled : 12:20) - biospace.com/
PTGX | $26.06 -1.96% 95K
|
Health Technology
|
| O: -1.94%
H: 1.7%
C: 0.05%
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023
Published: 2023-08-09 (Crawled : 12:20) - biospace.com/
SMMT | $3.5 -4.5% 360K
|
Health Technology
|
| O: -0.28%
H: 18.08%
C: 9.6%
six therapeutics financial results
Pliant Therapeutics Announces Initiation of BEACON-IPF, a Phase 2b Clinical Trial of Bexotegrast in Idiopathic Pulmonary Fibrosis
Published: 2023-08-09 (Crawled : 12:20) - globenewswire.com
PLRX | $13.51 -0.3% 70K
|
Health Technology
|
| O: -0.66%
H: 0.83%
C: 0.72%
fibrosis bexotegrast trial therapeutics
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
Published: 2023-08-08 (Crawled : 12:20) - globenewswire.com
MRSN | $3.8 0.26% 120K
|
Health Technology
|
| O: -1.68%
H: 5.98%
C: 5.13%
therapeutics financial results
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.